By
Drug Target Review2025-03-17T09:00:53
Scientists at the University of Virginia (UVA) School of Medicine have uncovered a crucial mechanism behind the lingering effects of long COVID, revealing how severe COVID-19 infections impair immune cells’ ability to repair lung tissue.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-08T09:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-07-03T09:00:00Z
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-04-12T15:28:08
Sponsored by nanoComposix
Site powered by Webvision Cloud